Statistics
Publications
23
Citations
7.8K
H-Index
21
Active since
1997
Colin Hessel is an author at Exelixis (United States) specializing in oncology, medicine, and cancer pharmacology.
Publications per year
1997–2023
23
23
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa, Tim Meyer, Ann‐Lii Cheng et al. · New England Journal of Medicine · 2018 · 2.3K citations · Full text
Medicine, Oncology, Pharmacology +16
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Cabozantinib in Progressive Medullary Thyroid Cancer
Rossella Elisei, Martin Schlumberger, Stefan Müller et al. · Journal of Clinical Oncology · 2013 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +14
Toni K. Choueiri, Colin Hessel, Susan Halabi et al. · European Journal of Cancer · 2018 · 400 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 23